Blood Collection Tubes for Liquid Biopsy Market Size by 2031
液体活检用采血管市场规模预计将从 2023 年的 1.1013 亿美元增至 2031 年的 4.2866 亿美元。预计 2023-2031 年期间市场复合年增长率将达到 18.5%。随着需要进行血液检测以进行诊断和监测病情进展的慢性病发病率不断上升,技术先进的液体活检用采血管很可能仍是市场的主要趋势。
液体活检采血管市场分析
推动液体活检采血管市场增长的关键因素之一是癌症发病率的不断上升以及对非侵入性诊断工具的需求不断增加。随着用于早期疾病检测的新生物标记物研发活动的不断开展,液体活检采血管市场也在不断扩大。吞吐量采血管的发展表明,为液体活检程序设计的采血管有了显著的改进。
液体活检采血管市场概况
随着癌症发病率的上升,印度对液体活检等高度复杂、侵入性较小的诊断技术的需求也在增加。由于这些程序具有微创性,因此可以比传统的组织活检更频繁地进行。因此,随着印度实施的液体活检程序数量的激增,用于液体活检的采血管市场正在大幅扩张。据印度医学研究理事会称,2022 年印度诊断出的癌症新病例估计为 146 万例。在印度,预计每 9 人中就有 1 人在一生中的某个时刻被诊断出患有癌症。乳腺癌是女性中最常见的癌症,而肺癌是男性中最常见的癌症类型。淋巴细胞白血病是儿童中最常见的癌症类型,影响 0-14 岁年龄段的 29.2% 的男孩和 24.2% 的女孩。不断取得的进步,例如增强的检测技术和更灵敏的设备,正在使液体活检程序更加可靠和易于使用。此外,随着人们对液体活检优势的认识不断提高,包括早期检测、治疗效果监测和预防复发,预计将在未来几年使印度等发展中国家的市场受益。
定制研究以满足您的需求
我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。
液体活检采血管市场:
复合年增长率(2023 - 2031)18.5%- 2023 年市场规模
1.1013 亿美元 - 市场规模 2031
4.2866 亿美元
市场动态
- 癌症发病率上升
- 液体活检的技术进步
- 液体活检在癌症监测中的应用
关键人物
- Biocept公司
- F. 霍夫曼-罗氏有限公司
- 斯特莱克公司
- Norgen Biotek 公司
- 精确科学公司
- MagBio Genomics 公司
- Zymo 研究公司
- 使徒科学
- 凯杰公司
- Greiner BioOne 国际有限公司
区域概况
- 北美
- 欧洲
- 亚太
- 南美洲和中美洲
- 中东和非洲
市场细分
- ccfDNA/cfDNA 管
- cfRNA 管
- CTC 管
- gDNA 管
- 细胞内 RNA 管
- 塑料
- 玻璃
- 体外诊断
- 研究
- 基因诊断实验室
- 研发中心
- 传统诊断中心
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
液体活检采血管市场驱动因素和机遇
液体活检相较于其他诊断检测技术的优势有利于市场增长
侵入性诊断程序会增加血肿、出血和组织损伤的风险,从而将肿瘤细胞植入周围组织。因此,越来越多的患者倾向于进行非侵入性或微创性检测以进行诊断。研究人员可以通过对血液样本进行液体活检来追踪实体肿瘤中的所有遗传和表观遗传变化。由于液体活检是一种非侵入性诊断技术,因此患者的风险较小。此外,临床医生可以轻松地多次进行这些测试,因为这些程序不会给患者带来太多不适。患者更喜欢微创手术,因为可以使用先进的仪器,这些仪器可以让临床医生或实验室人员进行更精细和复杂的工作,而不会造成太多疼痛、疤痕和其他风险。由于技术进步提高了可行性并缩短了处理时间,液体活检作为癌症患者组织活检的非侵入性替代方案,最近引起了广泛关注。
计算机断层扫描 (CT)、磁共振成像 (MRI) 和正电子发射断层扫描 (PET) 等成像技术既昂贵又耗时。此外,它们还会使患者暴露于外部辐射、静脉造影剂和放射性示踪剂等。成像研究也无法提供有关肿瘤表型的任何信息,而肿瘤表型可能会随着所给予的治疗而改变。尽管组织活检技术可以提供有关肿瘤表型的信息,但考虑到成本限制和患者风险,进行连续组织活检是不可行的。相反,液体活检可以以相对较低的成本提供几乎连续的癌症负担和表型信息评估。液体活检提供了评估各种生理或病理生理过程的非侵入性或微创方法,从而取代了组织活检或其他侵入性程序。在这种情况下,液体活检可以通过分析血液样本中的循环肿瘤细胞或循环游离核酸来避免内窥镜检查、针吸活检或手术的需要。
液体活检在癌症监测中的应用为市场提供增长机会
研究人员高度关注液体活检程序在监测癌症生长、检测基因突变、识别复发迹象和预测免疫疗法敏感性方面的能力。早期发现癌症可带来更好的结果;例如,早期发现的患者的缓解率和存活率高于晚期或恶性癌症患者。然而,在症状不明显的早期阶段进行连续放射学检测或侵入性癌症监测程序以检测癌症是不切实际的。液体活检开启了通过常规抽血或尿液分析进行定期癌症筛查的可能性。它可以识别高度特异性和循环标记物以进行早期癌症检测。
液体活检程序也用于癌症患者的治疗后监测。治疗后,癌细胞可能在体内持续存在,但其水平低于影像学研究的分辨率和检测水平;这种情况被称为微小残留病。这种疾病被认为是癌症缓解的主要原因。与癌症筛查和早期检测类似,液体活检的临床应用受到当前测试的敏感性和特异性的限制。这种敏感性限制使得液体活检技术更适合检测实体肿瘤而非血癌的微小残留病。借助液体活检,医疗保健专业人员可以监测癌症复发的情况,然后通过正确的诊断尽早治疗。
最初对特定酪氨酸激酶抑制剂(包括吉非替尼、厄洛替尼、克唑替尼和色瑞替尼)敏感的肿瘤经常发生变异并对这些药物产生耐药性。液体活检可检测肿瘤状态的变化,并帮助医生修改治疗策略,以避免患者体内对任何药物产生耐药性。因此,液体活检可以早期发现癌症,并帮助医疗保健专业人员确定确切的治疗方案。此外,它还有助于监测治疗和治疗后患者的状况。因此,人们越来越关注液体活检在癌症患者监测中的应用,这可能会在预测期内对液体活检程序的采血管产生大量需求。
液体活检采血管市场报告细分分析
促成液体活检采血管市场分析的关键部分是产品、材料、应用和最终用户。
- 根据产品,液体活检采血管市场分为 ccfDNA 管、cfRNA 管、CTC 管、gDNA 管、细胞内 RNA 管等。ccfDNA/cfDNA 管细分市场在 2023 年占据最大市场份额。
- 根据材料,液体活检采血管市场分为玻璃和塑料。2023 年,塑料部分占据了较大的市场份额。
- 根据应用,市场分为体外诊断 (IVD) 和研究。体外诊断 (IVD) 领域在 2023 年占据了更大的市场份额。
- 根据最终用户,液体活检采血管市场分为基因诊断实验室、研发中心、传统诊断中心等。基因诊断实验室部分在 2023 年占据了最大的市场份额。
液体活检采血管市场份额(按地区)分析
液体活检采血管市场报告的地理范围主要分为五个地区:北美、亚太地区、欧洲、南美和中美以及中东和非洲。2023 年,北美占据了市场主导地位。技术先进产品的接受度不断提高、研发活动的增加、大型医疗保健企业的存在以及 FDA 对液体活检的批准数量不断增加,是推动北美液体活检采血管市场发展的关键因素。预计亚太地区在预测期内的复合年增长率最高。随着癌症患病率的飙升、对创新诊断解决方案开发的高支出以及重要市场参与者的存在,美国的液体活检程序市场正在蓬勃发展。
液体活检采血管市场报告范围
报告属性 | 细节 |
---|---|
2023 年的市场规模 | 1.1013亿美元 |
2031 年市场规模 | 4.2866亿美元 |
全球复合年增长率(2023 - 2031) | 18.5% |
史料 | 2021-2022 |
预测期 | 2024-2031 |
涵盖的领域 | 按产品
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
液体活检采血管市场新闻及最新发展
通过收集一手和二手研究后的定性和定量数据来评估液体活检采血管市场,其中包括重要的公司出版物、协会数据和数据库。近年来市场发生的重大发展之一如下:
- Exact Science Corporation 宣布在马里兰州巴尔的摩市建立 Haystack Oncology 设施。这家新企业最近筹集了 5600 万美元的资金,由纽约投资公司 Catalio Capital Management 领投。Haystack 正在开发一种血液检测方法,可以检测出来自实体肿瘤的微量循环 DNA,从而表明癌症的存在及其可能的复发。(来源:Exact Science Corporation,公司网站,2022 年 11 月)
液体活检采血管市场报告覆盖范围和交付成果
“液体活检采血管市场规模和预测(2021-2031)”报告对市场进行了详细的分析,涵盖以下领域:
- 液体活检用采血管市场规模及预测,涵盖范围涵盖的所有关键细分市场的全球、区域和国家层面
- 液体活检采血管市场趋势以及市场动态,如驱动因素、限制因素和关键机遇
- 详细的 PEST/波特五力分析和 SWOT 分析
- 液体活检采血管市场分析,涵盖关键市场趋势、全球和区域框架、主要参与者、法规和最新市场发展
- 行业格局和竞争分析,涵盖市场集中度、热图分析、知名参与者以及液体活检采血管市场的最新发展
- 详细的公司简介
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Biocept Inc, F. Hoffmann-La Roche Ltd; Streck Inc; Norgen Biotek Corp; Exact Sciences Corp; MagBio Genomics, Inc; Zymo Research Corporation; Apostle Sciences; QIAGEN NV; and Greiner Bio-One International GmbH are among the key players in the market.
The estimated value of the market would be US$ 428.66 million by 2031.
The market is expected to register a CAGR of 18.5% during 2023–2031.
Technological advancements in liquid biopsy would bring new growth trends in the market in the coming years.
North America dominated the market in 2023.
An increase in the prevalence of cancer and the advantages of liquid biopsy over other diagnostic testing techniques are among the most influential factors propelling the market growth.
The List of Companies - Collection Tubes for Liquid Biopsy Market
- Biocept Inc
- F. Hoffmann-La Roche Ltd
- Streck Inc
- Norgen Biotek Corp
- Exact Sciences Corp
- MagBio Genomics, Inc
- Zymo Research Corporation
- Apostle Sciences
- QIAGEN NV
- Greiner Bio-One International GmbH
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.